Cancer of the Uterine Cervix at the University of Calabar Teaching Hospital, Calabar Nigeria
Cancer Research Journal
Volume 1, Issue 4, November 2013, Pages: 37-40
Received: Nov. 30, 2013; Published: Jan. 10, 2014
Views 3040      Downloads 173
Authors
Boniface Uji Ago, Department of Obstetrics and Gynaecology University of Calabar Teaching Hospital, Calabar, Nigeria; University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria
Thomas Udagbor Agan, Department of Obstetrics and Gynaecology University of Calabar Teaching Hospital, Calabar, Nigeria; University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria
Etim Inyang Ekanem, Department of Obstetrics and Gynaecology University of Calabar Teaching Hospital, Calabar, Nigeria; University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria
Article Tools
PDF
Follow on us
Abstract
Background: This study was carried out to highlight the prevalence of cancer of the uterine cervix and shortcoming in the management of cervical cancer in our hospital. There is the need to improve on our personnel training and equipment acquisition. Method: This was a retrospective study. Case folders of forty-seven patients who were diagnosed with cancer of the cervix were retrieved and reviewed. Information on age, parity, clinical presentation, stages of the disease and management as well as management problems were analyzed. Results: There were 1450 admissions into the gynaecology ward during the study. Forty patients had histologically confirmed cancer of the cervix. This gave cervical cancer a prevalence of 2.76% of gynaecology ward admissions in this center. 82.5% presented with late stage disease where little or nothing could be done for them. Conclusion: Cancer of the uterine cervix is still a problem in our setting where uptake of screening methods and the availability of cytopathologists are still dismally low.
Keywords
Cancer, Uterine Cervix, Management
To cite this article
Boniface Uji Ago, Thomas Udagbor Agan, Etim Inyang Ekanem, Cancer of the Uterine Cervix at the University of Calabar Teaching Hospital, Calabar Nigeria, Cancer Research Journal. Vol. 1, No. 4, 2013, pp. 37-40. doi: 10.11648/j.crj.20130104.12
References
[1]
Cancer advances in focus. Cervical cancer. National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/cancer-advances-in-focus/cervical accessed Dec 18th 2013
[2]
Cecilia H. Boardman. Cervical cancer. Medscape Medical online. http://www.emedicine.medscape.com/article/253513. Accessed December 18th 2013
[3]
Adewole IF. Epidemiology, clinical features and management of cervical cancer. In: Okonofua F and Odunsi K (eds). Contemporary Obstetrics and Gynaecology for the developing countries. Women’s Health and Action Research Center Benin 2003; 289-315.
[4]
Monsonego J. Cervical neoplasia from morphology to molecular biology. In: Monsonego J (ed). Pappilomavirus in human pathology. Challenges of modern medicine Vol 9 Ares sorono symposia 1995; 29-53.
[5]
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, EI Ghissassi F, et al. A review of human carcinogens—part B: biologic agents. Lancet Oncol. April 2009;10(4):321-2
[6]
de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. A retrospective cross-sectional worldwide study. Lancet Oncol. Nov 2010;11(11):1048-56
[7]
HIVinfection and cancer risk. National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/Risk/hiv-infection. Accessed Dec 22nd 2013
[8]
Edozien LC and Adewole IF. Cervical carcinoma in Nigeria – A need for early detection. Afr. J. Med & Med. Sci. 1993; 22: 87-92.
[9]
Disaia PJ and Creasman WT (ed). Invasive cervical cancer. ClinicalGynaecologic Oncology Fourth edition. Mosby Year book Inc, 1993; 29-53.
[10]
Neerja Bhatla (ed). Carcinoma of the cervix. Jeffcoate’s Principles of Gynaecology. International edition. Arnold 2001; 447-465.
[11]
Parkin DM. Screening for cervical cancer in developing countries. In: Miller AB, Chamberlain J, Day NE, Hakama M and Porok PC (eds). Cancer screening. Cambridge: UICC Cambridge University Press 1991; 184-198.
[12]
Gawande V, Wahab SN, Zodney and Vasudee ND. Parity as a risk factor for cancer cervix. Indian J. Med. Sci. 1998; 52 (4): 147-150.
[13]
Lakewood Pathology associates. Epidemiology of cervical cancer. Women’s Health 2001.
[14]
Kjorstad KE. Treatment complications in patients with early stage cervical cancer. In: Burghart E and Monaghar JM (eds). Operative treatment of cervical cancer. Bailleres Clinical Obstetrics and Gynaecology 1998; 2(4): 963-970.
[15]
Brooks M. One HPV shot may be enough to protect against cervical cancer. Medscape Medical News online. http://www.medscape.com/viewarticle/813780. Accessed 23rd December 2013
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186